ADMA Biologics
ADMA
ADMA
23 hedge funds and large institutions have $67.9M invested in ADMA Biologics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$845K | |
| 2 | +$757K | |
| 3 | +$40.5K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$34.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$130K | |
| 3 | -$121K | |
| 4 |
Goldman Sachs
New York
|
-$107K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$32K |